Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol for Transient Tachypnoea of the Newborn
NCT05527704Phase 3Active, not recruiting
- Sponsor
- Medical University of Warsaw
- Start
- Dec 2021
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salbutamol in transient tachypnea of the newborn (TTN), sponsored by Medical University of Warsaw. Started Dec 2021; status: active, not recruiting.
02
Drugs
salbutamol
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on NCT05527704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05527704.